The MHRA has published further guidance in relation to supplying medicines and medical devices after the end of the transition period. On medicines we have the following updates: Sourcing medicines for the Great Britain market from an approved country for …Read More »
GDP monographs will be the main topic of the webinar presented by Phil Butson (PQG) on Tuesday, 27 October. The live webinar (GDP Requirements and the ECA/PQG Good Distribution Practice monographs) will be held on behalf of Pharmaceutical Quality Group …Read More »
PQG’s second Trainee QP CPD – Virtual Event will be held on the 20th October 2020. To facilitate the interactive nature of this meeting the number of delegates will be restricted to 30. More details and bookings here. David Moulding …Read More »
On Tuesday 22 September 2020 PQG organised a Data Integrity Webinar with Dale Carter, Head of Quality – Evonik Corporation. In this presentation, Dale reviewed the recently released position paper on Data Integrity for Pharmaceutical Grade Excipients published by the International Pharmaceutical Excipients …Read More »
Just in case you missed some of this week’s news, here are the highlights: MHRA published on 1 September 2020 guidance for industry and organisations to follow after the end of the transition period. From 1 January 2021, the Medicines and …Read More »
From 1 January 2021, a wholesale dealer in Great Britain may only import Qualified Person (QP) certified medicines from the European Economic Area (EEA) if certain checks are made by the ‘Responsible Person (import) (RPi)’. The guidance published on 1 …Read More »
IPEC have issued a position paper outlining the content and purpose of three documents* addressing GMP requirements for excipients and the role that each can play in the implementation of appropriate GMP in the QMS of an excipient manufacturer. This …Read More »
Our very first virtual event was held on 30th June, dedicated to our QPs, Trainee QP and Sponsors. The event was held using the “WebEx Training” platform and limited to 30 attendees. The attendees varied in background and experience, from …Read More »
The MHRA has published further guidance in relation to supplying medicines and medical devices after the end of the transition period. On medicines we have the following updates: Sourcing medicines for the Great Britain market from an approved country for import or Northern Ireland from 1 January 2021 Importing investigational medicinal products into Great Britain...
Read more
GDP monographs will be the main topic of the webinar presented by Phil Butson (PQG) on Tuesday, 27 October. The live webinar (GDP Requirements and the ECA/PQG Good Distribution Practice monographs) will be held on behalf of Pharmaceutical Quality Group as part of MP’s Digital Week. During the Digital Week, Making Pharmaceuticals brings you a...
Read more
PQG’s second Trainee QP CPD – Virtual Event will be held on the 20th October 2020. To facilitate the interactive nature of this meeting the number of delegates will be restricted to 30. More details and bookings here. David Moulding (Registration Standards Specialist, RSC) will give a presentation on Applying for QP Eligibility. In the...
Read more
On Tuesday 22 September 2020 PQG organised a Data Integrity Webinar with Dale Carter, Head of Quality – Evonik Corporation. In this presentation, Dale reviewed the recently released position paper on Data Integrity for Pharmaceutical Grade Excipients published by the International Pharmaceutical Excipients Council Federation (IPEC). The paper was developed to supplement published Regulatory guidance defining Data Integrity requirements...
Read more
Just in case you missed some of this week’s news, here are the highlights: MHRA published on 1 September 2020 guidance for industry and organisations to follow after the end of the transition period. From 1 January 2021, the Medicines and Healthcare products Regulatory Agency (MHRA) will be the UK’s standalone medicines and medical devices regulator....
Read more